← Back to Patent Explorer
US4080261A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel endonuclease and process for production thereof

Assignee: RIKEN
•
Filing: 1976-10-06
•
Granted: 1978-03-21
•
Expires: 1996-10-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to new enzymes which decompose nucleic acid and are endowed with a substrate specificity recognizing specific biological desoxyribonucleic acid and cleaving specific bonds thereof to produce fragments of desoxyribonucleic acid of specific sizes and which are obtained by culturing microorganisms belonging to genus Bucillus and purifying the cell free extract thereof by such treatment as streptomycin treatment, ammonium sulfate precipitation, ion exchange chromatography, gel filtration or combination of these processes.

Inventors

  • 👤 Takehiko Shibata
  • 👤 Tadahiko Ando

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 23:12
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/14; C12N9/16; C12N9/22

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 141 words
Endonuclease R NI capable of selectively recognizing specific nucleic acids and cleaving the phosphodiester bond in the nucleic acids at at least one nonterminal position to produce nucleic acid fragments having discrete molecular weight, of molecular weight between 10,000 and 100,000 capable of cleaving Coli phage λ in 5 positions, λ dv I DNA and Simian Virus 40 in one position, having an activity of optimum pH range 7.2-8.3, having optimum temperature range at 35°-37° C, activated by 0.3-10 mM of Mg+ 2 , inhibited by more than 20 mmM of Mg+ 2 and more than 0.2 M of NaCl, inhibited by 5 mM of EDTA, said enzyme being obtained from a cell-free extract of the species IAM 1522 and ATCC 23,845 of Genus Bacillus in a culture medium, collecting the cells thereof, obtaining cell free extract therefrom, fractionating said extract.
Claim 2
Dependent Claim 141 words
Endonuclease R NI capable of selectively recognizing specific nucleic acids and cleaving the phosphodiester bond in the nucleic acids at at least one nonterminal position to produce nucleic acid fragments having discrete molecular weight, of molecular weight between 10,000 and 100,000 capable of cleaving Coli phage λ in 5 positions, λ dv I DNA and Simian Virus 40 in one position, having an activity of optimum pH range 7.2-8.3, having optimum temperature range at 35°-37° C, activated by 0.3-10 mM of Mg+ 2 , inhibited by more than 20 mmM of Mg+ 2 and more than 0.2 M of NaCl, inhibited by 5 mM of EDTA, said enzyme being obtained from a cell-free extract of the species IAM 1522 and ATCC 23,845 of Genus Bacillus in a culture medium, collecting the cells thereof, obtaining cell free extract therefrom, fractionating said extract.
Claim 3
Dependent Claim 134 words
Endonuclease R NII capable of selectively recognizing specific nucleic acids and cleaving the phosphodiester bond in the nucleic acids to produce nucleic acid fragments having discrete molecular weight, of molecular weight about 100,000, capable of cleaving Bacillus phage φ 105 C-168 in 16 positions, Coli phage λ in about 15 positions, Coli phage T7 in about 10-15 positions, λ dv I DNA in 2 or 3 positions, Col EI in three positions, Simian virus 40 at more than four positions, activated by 10-20 M of Mg 2+ , inhibited by more than 0.2M of NaCl, inhibited by 5 mM of EDTA, said enzyme being obtained from a cell-free extract of the species IAM 1522 and ATCC 23,845 Bacillus in a culture medium, collecting the cells thereof, obtaining cell free extract therefrom, fractionating said extract.
Claim 4
Dependent Claim 134 words
Endonuclease R NII capable of selectively recognizing specific nucleic acids and cleaving the phosphodiester bond in the nucleic acids to produce nucleic acid fragments having discrete molecular weight, of molecular weight about 100,000, capable of cleaving Bacillus phage φ 105 C-168 in 16 positions, Coli phage λ in about 15 positions, Coli phage T7 in about 10-15 positions, λ dv I DNA in 2 or 3 positions, Col EI in three positions, Simian virus 40 at more than four positions, activated by 10-20 M of Mg 2+ , inhibited by more than 0.2M of NaCl, inhibited by 5 mM of EDTA, said enzyme being obtained from a cell-free extract of the species IAM 1522 and ATCC 23,845 Bacillus in a culture medium, collecting the cells thereof, obtaining cell free extract therefrom, fractionating said extract.
Claim 5
Dependent Claim 50 words
Process for producing endonuclease R Bam NI, R Bam NII and R Bam NIII which comprises cultivating a strain of Species IAM 1522 or ATCC 23,845 of Genus Bacillus in a culture medium, collecting the cells thereof, obtaining cell free extract therefrom, fractionating said extract and purifying the fractionated extract.
Claim 6
Dependent Claim 50 words
Process for producing endonuclease R Bam NI, R Bam NII and R Bam NIII which comprises cultivating a strain of Species IAM 1522 or ATCC 23,845 of Genus Bacillus in a culture medium, collecting the cells thereof, obtaining cell free extract therefrom, fractionating said extract and purifying the fractionated extract.
Claim 7
Dependent Claim 13 words
Process according to claim 3 wherein said endonuclease is Endonuclease R. Bam NI.
Claim 8
Dependent Claim 13 words
Process according to claim 3 wherein said endonuclease is Endonuclease R. Bam NII.
Claim 9
Dependent Claim 13 words
Process according to claim 3 wherein said endonuclease is Endonuclease R. Bam NIII.

References Cited (Backward Citations)

US3956064A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-03-20 1981-09-19 1982-03-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-03-20 1985-09-19 1986-03-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-03-20 1989-09-19 1990-03-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag